What is LH's current stock price?

As of now, LH is trading at $255.81, with a daily change of -0.89%.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

LH Stock Analysis & IQ Rating | Laboratory Corporati

LH

Laboratory Corporati

$255.81

-$2.30 | -0.89%

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$293.72

MKT CAP

$21.21B

52W Low

$209.38

VOL

$630.95K

P/E Ratio

25.12

AVG VOL

$852.76K

RSI

39.10

TREND

Sideways

LH Stock IQ

Login to see Laboratory Corporati (LH) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

LH Target Price

Login to display

Strengths

LH Rewards

Earnings are forecast to grow

LH Rewards

Trading below its fair value

LH Price Performance

$261.37 (-2.13%)

$278.9 (-8.28%)

$261.72 (-2.26%)

$228.85 (+11.78%)

1year

6month

3month

1month

LH Risk Level

LH has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Risks Indicators

Investors losing confidence

Low

LOW

HIGH

LH Analysts Opinion

LH overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

LH Analysts Opinion

LH Analysts opinion is negative and it remained unchanged from the past 3 months

LH Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential

92%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

NA

0%

100%

LH Street Sentiment

LH Street Sentiment is extremely bullish and have positive views on the near-term outlook

LH Performance Sentiment

Sentiments overview associated with LH events and the stock performance.

92%

4%

Positive

Negative

22 out of 24
events present

1 out of 24
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Linked to LH

IQ

Close Price

Change

EXAS

4.32

101.61

-0.15%

DGX

2.75

179.10

+0.25%

HUM

3.72

260.28

+0.82%

GH

2.33

97.47

-2.53%

LH Latest Analysis +

Roche announces United States launch of next-generation cobas 6800/8800 systems and software enhancing laboratory efficiency and testing capabilities. The new cobas®. 6800/8800 Systems version 2.0 and software version 2.0.1 enhances throughput run flexibility enables sample prioritization and is available as an upgrade to existing systems.Laboratories can now perform a greater variety of tests per run simplifying laboratory logistics and helping to optimize the use of resources.The update ad

Tue Dec 16, 2025

$258.11 | -2.02%

Activity

A NEW STRATEGIC CHAPTER BEGINS AS ALBEMARLE PARTNERSHIP CLEARS THE PATH TO CASE LAKE PRODUCTION. Major HighlightsGlobal chemicals powerhouse Albemarle delivers non-dilutive investment Exceptional grades and simple processing position Case Lake as a standoutProduction momentum grows with strong permitting progressStrong Indigenous support with Apitipi Anicinapek Nation signing Participation AgreementDevelopment underway of Impacts Benefits Agreement with Apitipi Anicinapek Nation".Power Metals

Tue Dec 16, 2025

$258.11 | -2.02%

Activity

Global Molecular Cytogenetics Market Set to Reach USD 1.43 Billion by 2030 | MarketsandMarkets™. Delray Beach FL Dec. 11 2025 (GLOBE NEWSWIRE) -- Emerging markets breakthrough technologies and strategic M&.A reshape competitive landscapeThe global is projected to reach USD 1.43 billion by 2030 from USD 1.02 billion in 2025 at a CAGR of 7.1% from 2025 to 2030. The surge is attributed to rapidly increasing global cancer rates growing genetic disorder prevalence and the expanding adoption of ad

Thu Dec 11, 2025

$264.73 | +1.05%

Activity

Potential

The Jackson Laboratory receives an up to $30 million contract award to revolutionize drug safety testing with AI-powered virtual hearts. New CARDIOVERSE project combines AI stem cells and genetic variation to predict drug safety before human trials BAR HARBOR Maine Dec. 8 2025 /PRNewswire/ -- Developing new drugs is one of the riskiest and most expensive endeavors in science. Today The Jackson Laboratory (JAX)...

Mon Dec 8, 2025

$259.94 | +0.63%

Activity

SMT Corp Expands ISO/IEC 17025 and SAE AS6171 Accreditations to UK Laboratory Strengthening Global Counterfeit Detection Capabilities. SANDY HOOK Conn. Dec. 5 2025 /PRNewswire/ -- SMT Corp a global leader in the sourcing and advanced testing of electrical electronic and electromechanical (EEE) components today announced a significant expansion of its accreditation portfolio. The companys ISO/IEC 17025:2017 and...

Mon Dec 8, 2025

$259.94 | +0.63%

Activity

Lloyds completes its first India-UK digital Letter of Credit on WaveBL. WILMINGTON Del. Dec. 3 2025 /PRNewswire/ -- Lloyds and WaveBL a blockchain-based platform for digital trade documents have successfully completed a digital Letter of Credit (LC) transaction. The transaction a Documentary Credit in favour of West Yorkshire-based laboratory equipment...

Wed Dec 3, 2025

$265.76 | -0.08%

Activity

Polyrizon Hits Key Breakthrough That Brings Its Nasal Spray Closer To 2026 Trials. ) stock rose Tuesday with a session volume of 70.8 million compared to the average volume of 178.92 thousand as .The biotechnology company developing intranasal products based on its proprietary Capture &. Contain (C&.C) platform said it completed a major manufacturing upscaling milestone for its proprietary nasal-spray product platform.During the upscaling process Polyrizon and its manufacturing partner tra

Tue Dec 2, 2025

$265.93 | -0.66%

Activity

TAE Technologies And UKAEA Partner To Commercialize Advanced Fusion Technology. New joint venture will develop neutral beams for fusion and accelerator innovations for non-fusion applications creating high-skilled jobs and establishing a critical supply chainTAE Technologies a leading US private fusion energy firm with over 25 years at the forefront of scientific innovation today announces a bilateral and reciprocal investment commitment with the UK Atomic Energy Authority (UKAEA) to commerciali

Tue Dec 2, 2025

$265.93 | -0.66%

Activity

Potential

CEO Of Medpace Hldgs Sold $34.07M In Stock. MEDP) executed a substantial insider sell on December 1 according to an SEC filing.United States Securities and Exchange Commission on Monday showed that Troendle sold 56482 shares of Tracking the Tuesday'.s morning session Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology pharmaceutical and medical device firms. It also offers ancillary

Tue Dec 2, 2025

$265.93 | -0.66%

Activity

Fulcrum Therapeutics to Host Investor Event to Review New Clinical Data from the PIONEER trial of Pociredir in Sickle Cell Disease on December 7 2025. CAMBRIDGE Mass. Dec. 02 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics Inc.®. (NASDAQ:) a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases will host an investor event on Sunday December 7 2025 at 7:00 a.m. ET to review new clinical data from th

Tue Dec 2, 2025

$265.93 | -0.66%

Activity

FAQ About LH Stock Insights

What is LH current stock price?

What are LH stock strengths?

What is LH Risk Level?

What is LH market cap and volume?

What is LH current Stock IQ?

Should I buy LH stock right now?

Is LH a Strong Buy right now?

What does a 'Strong Buy' rating mean for LH?

What does a 'Strong Sell' rating mean for LH?

What factors influence LH's Stock IQ?

Explore our LH Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored LH Stock Strategies
Effective Risk Management

FIND US ON

Receive our LH Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

LH

Laboratory Corporati

Current Price

$255.81

-$2.30 | -0.89%

52W High

$293.72

MKT CAP

$21.21B

52W Low

$209.38

VOL

$630.95K

P/E Ratio

25.12

AVG VOL

$852.76K

RSI

39.10

TREND

Sideways

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

LH Rewards

Earnings are forecast to grow

LH Rewards

Trading below its fair value

Linked to LH

Symbol

IQ

Close

Change

EXAS

4.32

101.61

-0.15%

DGX

2.75

179.10

+0.25%

HUM

3.72

260.28

+0.82%

GH

2.33

97.47

-2.53%

LH Price Performance

$261.37 (-2.13%)

$278.9 (-8.28%)

$261.72 (-2.26%)

$228.85 (+11.78%)

1year

6month

3month

1month

LH Analysts Opinion

LH Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

LH Analysts Opinion

LH Analysts opinion is negative and it remained unchanged from the past 3 months

LH Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential

92%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

NA

0%

100%

LH Street Sentiment

LH Street Sentiment is extremely bullish and have positive views on the near-term outlook

LH Risk Level

LH has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Risks Indicators

Investors losing confidence

Low

LOW

HIGH

LH Performance Sentiment

Sentiments overview associated with LH events and the stock performance.

92%

4%

Positive

Negative

22 out of 24
events present

1 out of 24
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

LH Stock IQ

Login to unlock Laboratory Corporati (LH) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

LH Latest Analysis

Roche announces United States launch of next-generation cobas 6800/8800 systems and software enhancing laboratory efficiency and testing capabilities. The new cobas®. 6800/8800 Systems version 2.0 and software version 2.0.1 enhances throughput run flexibility enables sample prioritization and is available as an upgrade to existing systems.Laboratories can now perform a greater variety of tests per run simplifying laboratory logistics and helping to optimize the use of resources.The update ad

Tue Dec 16, 2025

$258.11 | -2.02%

Activity

A NEW STRATEGIC CHAPTER BEGINS AS ALBEMARLE PARTNERSHIP CLEARS THE PATH TO CASE LAKE PRODUCTION. Major HighlightsGlobal chemicals powerhouse Albemarle delivers non-dilutive investment Exceptional grades and simple processing position Case Lake as a standoutProduction momentum grows with strong permitting progressStrong Indigenous support with Apitipi Anicinapek Nation signing Participation AgreementDevelopment underway of Impacts Benefits Agreement with Apitipi Anicinapek Nation".Power Metals

Tue Dec 16, 2025

$258.11 | -2.02%

Activity

Global Molecular Cytogenetics Market Set to Reach USD 1.43 Billion by 2030 | MarketsandMarkets™. Delray Beach FL Dec. 11 2025 (GLOBE NEWSWIRE) -- Emerging markets breakthrough technologies and strategic M&.A reshape competitive landscapeThe global is projected to reach USD 1.43 billion by 2030 from USD 1.02 billion in 2025 at a CAGR of 7.1% from 2025 to 2030. The surge is attributed to rapidly increasing global cancer rates growing genetic disorder prevalence and the expanding adoption of ad

Thu Dec 11, 2025

$264.73 | +1.05%

Activity

Potential

The Jackson Laboratory receives an up to $30 million contract award to revolutionize drug safety testing with AI-powered virtual hearts. New CARDIOVERSE project combines AI stem cells and genetic variation to predict drug safety before human trials BAR HARBOR Maine Dec. 8 2025 /PRNewswire/ -- Developing new drugs is one of the riskiest and most expensive endeavors in science. Today The Jackson Laboratory (JAX)...

Mon Dec 8, 2025

$259.94 | +0.63%

Activity

SMT Corp Expands ISO/IEC 17025 and SAE AS6171 Accreditations to UK Laboratory Strengthening Global Counterfeit Detection Capabilities. SANDY HOOK Conn. Dec. 5 2025 /PRNewswire/ -- SMT Corp a global leader in the sourcing and advanced testing of electrical electronic and electromechanical (EEE) components today announced a significant expansion of its accreditation portfolio. The companys ISO/IEC 17025:2017 and...

Mon Dec 8, 2025

$259.94 | +0.63%

Activity

Lloyds completes its first India-UK digital Letter of Credit on WaveBL. WILMINGTON Del. Dec. 3 2025 /PRNewswire/ -- Lloyds and WaveBL a blockchain-based platform for digital trade documents have successfully completed a digital Letter of Credit (LC) transaction. The transaction a Documentary Credit in favour of West Yorkshire-based laboratory equipment...

Wed Dec 3, 2025

$265.76 | -0.08%

Activity

Polyrizon Hits Key Breakthrough That Brings Its Nasal Spray Closer To 2026 Trials. ) stock rose Tuesday with a session volume of 70.8 million compared to the average volume of 178.92 thousand as .The biotechnology company developing intranasal products based on its proprietary Capture &. Contain (C&.C) platform said it completed a major manufacturing upscaling milestone for its proprietary nasal-spray product platform.During the upscaling process Polyrizon and its manufacturing partner tra

Tue Dec 2, 2025

$265.93 | -0.66%

Activity

TAE Technologies And UKAEA Partner To Commercialize Advanced Fusion Technology. New joint venture will develop neutral beams for fusion and accelerator innovations for non-fusion applications creating high-skilled jobs and establishing a critical supply chainTAE Technologies a leading US private fusion energy firm with over 25 years at the forefront of scientific innovation today announces a bilateral and reciprocal investment commitment with the UK Atomic Energy Authority (UKAEA) to commerciali

Tue Dec 2, 2025

$265.93 | -0.66%

Activity

Potential

CEO Of Medpace Hldgs Sold $34.07M In Stock. MEDP) executed a substantial insider sell on December 1 according to an SEC filing.United States Securities and Exchange Commission on Monday showed that Troendle sold 56482 shares of Tracking the Tuesday'.s morning session Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology pharmaceutical and medical device firms. It also offers ancillary

Tue Dec 2, 2025

$265.93 | -0.66%

Activity

Fulcrum Therapeutics to Host Investor Event to Review New Clinical Data from the PIONEER trial of Pociredir in Sickle Cell Disease on December 7 2025. CAMBRIDGE Mass. Dec. 02 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics Inc.®. (NASDAQ:) a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases will host an investor event on Sunday December 7 2025 at 7:00 a.m. ET to review new clinical data from th

Tue Dec 2, 2025

$265.93 | -0.66%

Activity

Discover LH Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of LH. We're here to help you make informed investment decisions today.

FIND US ON

Receive our LH Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

LH Stock trends

LH Stock performance

LH Stock analysis

LH investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing LH

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing LH

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

LH Stock Analysis & IQ Rating | Laboratory Corporati

LH Stock IQ

LH Target Price

LH Risk Level

LH Analysts Opinion

LH Street Sentiment

LH Performance Sentiment

Explore our LH Stock insights

Receive our LH Daily Alerts

LH Street Sentiment

LH Risk Level

Discover LH Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of LH. We're here to help you make informed investment decisions today.

Receive our LH Daily Alerts

LH Runner Alarm